Your browser doesn't support javascript.
loading
Principal component analysis as an efficient method for capturing multivariate brain signatures of complex disorders-ENIGMA study in people with bipolar disorders and obesity.
McWhinney, Sean R; Hlinka, Jaroslav; Bakstein, Eduard; Dietze, Lorielle M F; Corkum, Emily L V; Abé, Christoph; Alda, Martin; Alexander, Nina; Benedetti, Francesco; Berk, Michael; Bøen, Erlend; Bonnekoh, Linda M; Boye, Birgitte; Brosch, Katharina; Canales-Rodríguez, Erick J; Cannon, Dara M; Dannlowski, Udo; Demro, Caroline; Diaz-Zuluaga, Ana; Elvsåshagen, Torbjørn; Eyler, Lisa T; Fortea, Lydia; Fullerton, Janice M; Goltermann, Janik; Gotlib, Ian H; Grotegerd, Dominik; Haarman, Bartholomeus; Hahn, Tim; Howells, Fleur M; Jamalabadi, Hamidreza; Jansen, Andreas; Kircher, Tilo; Klahn, Anna Luisa; Kuplicki, Rayus; Lahud, Elijah; Landén, Mikael; Leehr, Elisabeth J; Lopez-Jaramillo, Carlos; Mackey, Scott; Malt, Ulrik; Martyn, Fiona; Mazza, Elena; McDonald, Colm; McPhilemy, Genevieve; Meier, Sandra; Meinert, Susanne; Melloni, Elisa; Mitchell, Philip B; Nabulsi, Leila; Nenadic, Igor.
Afiliação
  • McWhinney SR; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Hlinka J; Department of Complex Systems, Institute of Computer Science, Czech Academy of Sciences, Prague, Czech Republic.
  • Bakstein E; National Institute of Mental Health, Klecany, Czech Republic.
  • Dietze LMF; National Institute of Mental Health, Klecany, Czech Republic.
  • Corkum ELV; Department of Cybernetics, Czech Technical University, Prague, Czech Republic.
  • Abé C; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Alda M; Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Alexander N; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Benedetti F; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Berk M; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Bøen E; National Institute of Mental Health, Klecany, Czech Republic.
  • Bonnekoh LM; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Boye B; Vita-Salute San Raffaele University, Milan, Italy.
  • Brosch K; Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Canales-Rodríguez EJ; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia.
  • Cannon DM; Unit for Psychosomatics/CL Outpatient Clinic for Adults, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Dannlowski U; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Demro C; Department of Child Adolescent Psychiatry and Psychotherapy, University of Münster, Münster, Germany.
  • Diaz-Zuluaga A; Unit for Psychosomatics and C-L Psychiatry for Adults, Oslo University Hospital, Oslo, Norway.
  • Elvsåshagen T; Department of Behavioural Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Eyler LT; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Fortea L; Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
  • Fullerton JM; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
  • Goltermann J; CIBERSAM, Instituto de Salud Carlos III, Barcelona, Spain.
  • Gotlib IH; Clinical Neuroimaging Laboratory, Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
  • Grotegerd D; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Haarman B; Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
  • Hahn T; Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellin, Colombia.
  • Howells FM; Department of Behavioural Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Jamalabadi H; Institute of Clinical Medicine, Norwegian Centre for Mental Disorders Research (NORMENT), University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Jansen A; Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
  • Kircher T; Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
  • Klahn AL; Desert-Pacific MIRECC, VA San Diego Healthcare, San Diego, California, USA.
  • Kuplicki R; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Instituto de Salud Carlos III, University of Barcelona, Barcelona, Spain.
  • Lahud E; Neuroscience Research Australia, Randwick, New South Wales, Australia.
  • Landén M; School of Biomedical Sciences, Faculty of Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Leehr EJ; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Lopez-Jaramillo C; Department of Psychology, Stanford University, Stanford, California, USA.
  • Mackey S; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Malt U; Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Martyn F; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Mazza E; Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • McDonald C; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • McPhilemy G; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Meier S; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Meinert S; Core-Facility Brainimaging, Faculty of Medicine, University of Marburg, Germany.
  • Melloni E; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Mitchell PB; Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
  • Nabulsi L; Laureate Institute for Brain Research, Tulsa, Oklahoma, USA.
  • Nenadic I; Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
Hum Brain Mapp ; 45(8): e26682, 2024 Jun 01.
Article em En | MEDLINE | ID: mdl-38825977
ABSTRACT
Multivariate techniques better fit the anatomy of complex neuropsychiatric disorders which are characterized not by alterations in a single region, but rather by variations across distributed brain networks. Here, we used principal component analysis (PCA) to identify patterns of covariance across brain regions and relate them to clinical and demographic variables in a large generalizable dataset of individuals with bipolar disorders and controls. We then compared performance of PCA and clustering on identical sample to identify which methodology was better in capturing links between brain and clinical measures. Using data from the ENIGMA-BD working group, we investigated T1-weighted structural MRI data from 2436 participants with BD and healthy controls, and applied PCA to cortical thickness and surface area measures. We then studied the association of principal components with clinical and demographic variables using mixed regression models. We compared the PCA model with our prior clustering analyses of the same data and also tested it in a replication sample of 327 participants with BD or schizophrenia and healthy controls. The first principal component, which indexed a greater cortical thickness across all 68 cortical regions, was negatively associated with BD, BMI, antipsychotic medications, and age and was positively associated with Li treatment. PCA demonstrated superior goodness of fit to clustering when predicting diagnosis and BMI. Moreover, applying the PCA model to the replication sample yielded significant differences in cortical thickness between healthy controls and individuals with BD or schizophrenia. Cortical thickness in the same widespread regional network as determined by PCA was negatively associated with different clinical and demographic variables, including diagnosis, age, BMI, and treatment with antipsychotic medications or lithium. PCA outperformed clustering and provided an easy-to-use and interpret method to study multivariate associations between brain structure and system-level variables. PRACTITIONER POINTS In this study of 2770 Individuals, we confirmed that cortical thickness in widespread regional networks as determined by principal component analysis (PCA) was negatively associated with relevant clinical and demographic variables, including diagnosis, age, BMI, and treatment with antipsychotic medications or lithium. Significant associations of many different system-level variables with the same brain network suggest a lack of one-to-one mapping of individual clinical and demographic factors to specific patterns of brain changes. PCA outperformed clustering analysis in the same data set when predicting group or BMI, providing a superior method for studying multivariate associations between brain structure and system-level variables.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Imageamento por Ressonância Magnética / Análise de Componente Principal / Obesidade Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Brain Mapp Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Imageamento por Ressonância Magnética / Análise de Componente Principal / Obesidade Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Brain Mapp Ano de publicação: 2024 Tipo de documento: Article